Chemcrux Enterprises
Chemcrux Enterprises Performance
Day Range
- Low
- High
52 Week Range
- Low
- High
- Open Price
- Previous Close
- Volume
Start SIP in Chemcrux Enterprises
Start SIPChemcrux Enterprises Investment Rating
-
Master Rating:
-
Chemcrux Enterprises has an operating revenue of Rs. 172.82 Cr. on a trailing 12-month basis. An annual revenue growth of 78% is outstanding, Pre-tax margin of 21% is great, ROE of 27% is exceptional. The company is debt free and has a strong balance sheet enabling it to report stable earnings growth across business cycles. The stock from a technical standpoint is trading below to its 50DMA and around 8% up from its 200DMA. It needs to take out the 50DMA levels and stay above it to make any further meaningful move. From an O'Neil Methodology perspective, the stock has an EPS Rank of 90 which is a GREAT score indicating consistency in earnings, a RS Rating of 86 which is GOOD indicating the outperformance as compared to other stocks, Buyer Demand at B- which is evident from recent demand for the stock, Group Rank of 158 indicates it belongs to a poor industry group of Medical-Biomed/Biotech and a Master Score of C is fair but needs to improve. Overall, the stock has great fundamentals and technical strength to stay in momentum.
EPS Strength
Price Strength
Buyer Demand
Group Rank
| Indicator | Sep 2022 | Jun 2022 |
|---|---|---|
| Oper Rev Qtr Cr | 28 | 27 |
| Operating Expenses Qtr Cr | 22 | 21 |
| Operating Profit Qtr Cr | 6 | 6 |
| Depreciation Qtr Cr | 0 | 0 |
| Interest Qtr Cr | 0 | 0 |
| Tax Qtr Cr | 1 | 1 |
| Net Profit Qtr Cr | 4 | 4 |
Chemcrux Enterprises Technicals
EMA & SMA
- Bullish Moving Average
- ___
- 4
- Bearish Moving Average
- ___
- 12
- 20 Day
- 360.72
- 50 Day
- 369.52
- 100 Day
- 366.33
- 200 Day
- 327.63
- 20 Day
- 361.88
- 50 Day
- 369.01
- 100 Day
- 394.62
- 200 Day
- 326.83
Chemcrux Enterprises Resistance and Support
| Resistance | |
|---|---|
| First Resistance | 366.32 |
| Second Resistance | 379.19 |
| Third Resistance | 389.82 |
| RSI | 41.19 |
| MFI | 36.69 |
| MACD Single Line | -3.99 |
| MACD | -4.43 |
| Support | |
|---|---|
| First Resistance | 342.82 |
| Second Resistance | 332.19 |
| Third Resistance | 319.32 |
Chemcrux Enterprises Delivery and Volume
| Period | NSE + BSE Volume Avg | NSE + BSE Delivery Volume Avg | NSE + BSE Delivery Volume % |
|---|---|---|---|
| Day | 17,182 | 1,058,239 | 61.59 |
| Week | 9,582 | 615,468 | 64.23 |
| 1 Month | 11,309 | 733,731 | 64.88 |
| 6 Month | 27,525 | 2,168,936 | 78.8 |
Chemcrux Enterprises Result Highlights
Chemcrux Enterprises Synopsis
BSE-Medical-Biomed/Biotech
Chemcrux Enterprises belongs to the Industry of Chemicals - Speciality - Others. Company’s Total Operating Revenue is Rs. 95.27 Cr. and Equity Capital is Rs. 14.81 Cr. for the Year ended 31/03/2022. Chemcrux Enterprises Ltd. is a Public Limited Listed company incorporated on 15/04/1996 and has its registered office in the State of Gujarat, India. Company’s Corporate Identification Number(CIN) is L01110GJ1996PLC029329 and registration number is 029329.| Market Cap | 537 |
| Sales | 150 |
| Shares in Float | 0.40 |
| No of funds | |
| Yield | 0.57 |
| Book Value | 9.56 |
| U/D Vol ratio | 0.5 |
| LTDebt / Equity | 1 |
| Alpha | 0.38 |
| Beta | 0.84 |
Chemcrux Enterprises
| Owner Name | Sep-22 | Jun-22 | Mar-22 |
|---|---|---|---|
| Promoters | 72.94% | 72.94% | 72.94% |
| Individual Investors | 25.26% | 24.88% | 24.69% |
| Others | 1.8% | 2.18% | 2.37% |
Chemcrux Enterprises Management
| Name | Designation |
|---|---|
| Mr. Girishkumar C Shah | Chairman & Wholetime Director |
| Mr. Sanjay Marathe | Managing Director |
| Mr. Mukund Bakshi | Ind. Non-Executive Director |
| Mrs. Neela S Marathe | Director |
| Mr. Shailesh H Patel | Independent Director |
| Mr. Bhanubhai V Patel | Independent Director |
Chemcrux Enterprises Forecast
Price Estimates
Chemcrux Enterprises Corporate Action
| Date | Purpose | Remarks |
|---|---|---|
| 2022-11-12 | Quarterly Results | |
| 2022-08-12 | Quarterly Results | |
| 2022-05-20 | Audited Results & Final Dividend | |
| 2022-02-19 | Others | Inter alia, to consider and approve Migration of equity shares of the company from SME Platform of BSE Limited to Main Board of BSE Limited subject to approval of the BSE Limited and shareholders per share(2.5%)Dividend |
| 2021-11-01 | Half Yearly Results |
| Date | Purpose | Remarks |
|---|---|---|
| 2022-09-16 | FINAL | Rs.2.00 per share(20%)Final Dividend |
| Date | Purpose | Remarks |
|---|---|---|
| 2021-09-07 | Bonus | Rs.0.00 issue of equity shares of in the ratio of 2:1 of Rs. 10/-. |
Chemcrux Enterprises FAQs
What is Share Price of Chemcrux Enterprises ?
Chemcrux Enterprises share price is ₹356 As on 30 January, 2023 | 14:25
What is the Market Cap of Chemcrux Enterprises ?
The Market Cap of Chemcrux Enterprises is ₹527.5 Cr As on 30 January, 2023 | 14:25
What is the P/E ratio of Chemcrux Enterprises ?
The P/E ratio of Chemcrux Enterprises is As on 30 January, 2023 | 14:25
What is the PB ratio of Chemcrux Enterprises ?
The PB ratio of Chemcrux Enterprises is 9.6 As on 30 January, 2023 | 14:25